Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
I
0007J0
vs
K
KOSPI 200
Over the past 12 months, 0007J0 has underperformed KOSPI 200, delivering a return of +7% compared to KOSPI 200's +108% growth.
Stocks Performance
0007J0 vs KOSPI 200
Performance Gap
0007J0 vs KOSPI 200
Performance By Year
0007J0 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Inventera Inc
Glance View
Inventera, Inc. engages in pharmaceutical research and development. The company is headquartered in Seoul, Seoul. The company went IPO on 2026-04-02. The firm principally develops and researches nano magnetic resonance imaging (MRI) contrast agents based on nanostructured drug delivery platform technologies. The firm's MRI contrast agent includes INV-002, INV-001 and INV-003, mainly used for the diagnosis and treatment of musculoskeletal, lymphatic, as well as pancreatobiliary diseases.